Otsuka Corporation




IT Services & Consulting

Market Closed - Japan Exchange 01:00:00 2023-12-04 am EST Intraday chart for Otsuka Corporation 5-day change 1st Jan Change
6,073 JPY +0.53% +2.05% +46.16%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jefferies: Investor Interest Shifts from Daiichi Sankyo to Chugai and Otsuka Holdings MT
US FDA approves Medtronic's blood pressure treatment device for use RE
Aurinia Pharmaceuticals Partner Otsuka Pharmaceutical Files New Drug Application For Voclosporin in Japan MT
FDA Approves Otsuka's Innovative Paradise Ultrasound System for Hypertension Treatment MT
US FDA approves Otsuka's blood pressure treatment device for use RE
Otsuka Holdings’ Attributable Profit up 45.6% in Nine-Month Period as Revenue Growth More than Offsets Impairment Losses MT
Lupin Gets US FDA Final Nod for Tolvaptan Tablets MT
Certain Shares of Nihon Knowledge Co,Ltd. are subject to a Lock-Up Agreement Ending on 20-SEP-2023. CI
Mindset Pharma Agrees to be Bought by Otsuka Pharmaceutical MT
Otsuka's Paradise Renal Denervation Device Receives Favorable Pre-Market Approval Votes from FDA Panel MT
Renova Signs 30-Year Purchase Agreement to Sell Non-FIT Non-Fossil Certs to Otsuka MT
First Solar Power G.K. Concludes an Environmental Value Sale and Purchase Agreement CI
US FDA panel backs Otsuka's blood pressure treatment device RE
US FDA Staff Reviewers Say No Issues Found With Medtronic, Otsuka Blood Pressure Devices MT
US FDA staff raise no concerns about Otsuka, Medtronic blood pressure devices RE
Otsuka Holdings’ Attributable Net Profit Up 47% in Q2 MT
Jefferies Adjusts Otsuka’s Price Target to 6,900 Yen From 5,900 Yen, Keeps at Buy MT
Otsuka Holdings Raises H1 Results Forecast; Shares Up 3% MT
Japan's Nikkei slips ahead of BOJ meeting, automakers top losers RE
Longeveron Names Lisa Locklear as CFO MT
Glass Lewis ESG Controversy Alert: Taisei Corporation MT
Earnings Fever Powers Japanese Equities Ship; Otsuka's Q1 Attributable Profit Zooms 164% MT
Otsuka's Q1 Attributable Profit Zooms 164%; Shares Rise 3% MT
Lundbeck Wins Expanded US FDA Nod for Antipsychotic Drug MT
Aurinia Pharmaceuticals Wins Swiss Approval for Kidney Disease Drug MT
Chart Otsuka Corporation
More charts
OTSUKA CORPORATION is a Japan-based company mainly engaged in the sale of system equipment, the installation support and maintenance services. The Company operates through two business segments. System Integration segment conducts consulting, hardware and software sales, contract software development, equipment installation and network construction. Service & Support segment provides office supply, maintenance services, as well as business support services. The Company is also involved in the car maintenance business and insurance business.
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
More Ratings
Mean consensus
Number of Analysts
Last Close Price
Average target price
Spread / Average Target
  1. Stock
  2. Equities
  3. Stock Otsuka Corporation - Japan Exchange
  4. News Otsuka Corporation
  5. Mindset Pharma Agrees to be Bought by Otsuka Pharmaceutical
As early as today, start finding the best investment opportunities!
Optimize my profits